The respiratory care devices market is projected to reach USD 33.6 billion by 2030 from USD 23.6 billion in 2025, at a CAGR of 7.3% from 2025 to 2030.
In the respiratory care devices market, companies are primarily focusing on strategies such as technological innovation, strategic partnerships, geographic expansion, and portfolio diversification to maintain a competitive edge. Key players such as Philips Healthcare, ResMed, Medtronic, and GE Healthcare are investing heavily in R&D to develop advanced, user-friendly, and portable devices such as non-invasive ventilators, CPAP machines, and smart inhalers that integrate with digital health platforms. Strategic collaborations with hospitals and healthcare providers are common, allowing companies to expand their customer base and enhance service delivery. Some of the prominent players operating in the market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), and Masimo (US).
To know about the assumptions considered for the study download the pdf brochure
Koninklijke Philips N.V. (Netherlands)
Koninklijke Philips N.V. (Netherlands) is a global health technology leader known for its strong presence in the respiratory care devices market, particularly through its innovative, non-invasive ventilators, CPAP/BiPAP machines, and home oxygen therapy systems. With a strategic focus on integrated care, Philips combines medical devices with AI-powered digital platforms such as HealthSuite to deliver connected solutions across hospital and home settings. The company’s core competencies lie in its robust R&D capabilities, global brand presence, and commitment to sustainability. Despite challenges from a global recall of certain respiratory devices, Philips continues to strengthen its position through new product launches. These efforts underline its leadership in delivering advanced, patient-centric respiratory care solutions globally.
Medtronic (Ireland)
Medtronic plc is one of the world’s largest medical technology companies, operating in over 150+ countries. The company has merged its remaining Patient Monitoring and Respiratory Interventions segments into a unified business unit named Acute Care & Monitoring. Its core competencies include its strong presence in chronic disease management, cutting-edge patient monitoring systems, surgical innovations, and global supply chain capabilities. Known for its continuous investment in R&D and digital health integration, the company excels in developing minimally invasive therapies, advanced monitoring devices, and AI-powered diagnostics. Despite withdrawing from ventilator manufacturing, the company remains a major player in hospital-based care solutions, focusing on innovation in acute monitoring and intervention technologies. This restructuring reflects the aim to streamline operations, enhance profitability, and concentrate on higher-growth segments in critical and surgical care.
Related Reports:
Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE